UNIPARENTAL DISOMY (UPD): A CONSEQUENCE OF NON-DISJUNCTION AND THE IMPLICATIONS IN PRENATAL DIAGNOSIS
Velissariou V*
*Corresponding Author: Dr. Voula Velissariou, Cytogenetics Laboratory, Department of Genetics and Molecular Biology, Mitera Hospital, Erythrou Stavrou 7, Maroussi, Athens 11523, Greece; Tel.: +30-210-686-9869; Fax: +30-210-689-9476; E-mail: voulavel@ hol.gr
page: 55

UNIPARENTAL DISOMY STUDIES IN PRENATAL DIAGNOSIS

According to the recent literature, UPD molecular studies should be performed in the following cases during prenatal diagnosis:

a) When mosaicism for chromosomes 6, 7, 11, 14, 15 and 16 is detected after chorionic villus sampling (CVS) and subsequent amniocentesis shows a normal fetal karyo­type, most likely caused by “trisomy rescue”. Theoreti­cally, in one-third of these cases UPD should be present in the euploid cell lines. For chromosome 20, evidence has accumulated during the past few years that it may be re­sponsible for abnormalities, when both chromosomes 20 are maternally derived, and it is advisable to offer UPD analysis [11,13,14]. For chromosomes 2, 4 and 5, there is still no convincing evidence that UPD may cause abnor­malities in order to justify molecular studies, when de­tected in a mosaic state in the placenta [5].

b) When a non homologous familial or de novo Robertsonian translocation involving chromosomes 14 and 15, known to contain imprinted genes, is detected either in CVS or amniotic fluid cells. According to Silverstein et al. [7], the risk estimate is 0.65%, which justifies UPD analysis in fetuses diagnosed prenatally with Roberstonian translocations. Based on this risk the same authors suggest testing these fetuses for UPD in amniocytes rather than chorionic villi, when the risk for unbalanced karyotype is ~1%, comparable to the risk for UPD.

c) When a homologous de novo Robertsonian trans­location or an isochromosome involving either chromo­some 14 or 15 is detected. Berend et al. [15] estimated that the risk of UPD, when a homologous acrocentric rear­rangement is identified prenatally, is approximately 66%, which certainly justifies UPD analysis.

d)   When a 47,+ESAC (extra structurally abnormal chromosome) karyotype is detected, it may infrequently coexist with UPD for the same chromosome that the ESAC was derived from; it may be that the zygote from a 23,abn + 23,N (46,abn) conception attempted to correct the imbalance, or at least lessen it, by replication of the normal homologue [16]. If the ESAC is derived from chro­mosome 15, known to contain imprinted genes, it is advis­able to perform UPD analysis.

 

 

Figure 2. Map of imprinted regions in the human genome, based on phenotypes detected in cases of UPD involving the maternally inherited homologues (left chromosome in each pair) or the paternally inherited homologues (right chromosome in each pair).[Modified from Ledbetter DH, Engel E: Uniparental disomy in humans: Development of an imprinting map and its implications for prenatal diagnosis. Hum Mol Genet 1995; 4: 1757-1764.]

   

 

Chromosome UPD and Inheritance

 

Associated Genetic Disease or Abnormalities

 

Paternal UPD 6

 

Transient neonatal diabetes mellitus

 

Maternal UPD 7

 

Silver-Russell syndrome

 

Paternal UPD 11

 

Beckwith-Wiedemann syndrome

 

Maternal UPD 14

 

Hypotonia, motor development delay, mild dysmorphic facial features, low birth weight, growth abnormalities

 

Paternal UPD 14

 

Severe mental and muscoskeletal abnormalities

 

Maternal UPD 15

 

Prader-Willi syndrome

 

Paternal UPD 15

 

Angelman syndrome

 

Maternal UPD 16

 

Intrauterine growth retardation

 

Maternal UPD 20

 

Intrauterine growth retardation and/or postnatal growth retardation

 

Table 2. Uniparental disomy and associated genetic disease.

 




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006